Expert provider survey of longitudinal assessment in patients with pulmonary arterial hypertension

Pulmonary arterial hypertension (PAH) is a progressive, highly morbid, and often fatal disease that requires extensive evaluation and careful patient monitoring, particularly during the first year after diagnosis.1,2 Expert-opinion guidelines suggest frequent patient evaluations with periodic re-assessments of laboratory, imaging and hemodynamic variables.3 Contemporary evidence also emphasizes the importance of initial risk assessment with validated tools.4 The need for subsequent risk modification in altering disease course calls for increased understanding of adequate, focused patient monitoring.

Source: Heart and Lung - November 10, 2022 Category: Intensive Care Authors: John F. Kingrey, Christine Y. Zhou, Bhavinkumar Dalal, Jean M. Elwing Source Type: research